OR-1855 (Standard), CAS [[101328-85-2]] Preis auf Anfrage

Artikelnummer: MCE-HY-W050000R
Artikelname: OR-1855 (Standard), CAS [[101328-85-2]] Preis auf Anfrage
Artikelnummer: MCE-HY-W050000R
Hersteller Artikelnummer: HY-W050000R
Alternativnummer: MCE-HY-W050000R-10MG,MCE-HY-W050000R-50MG,MCE-HY-W050000R-100MG,MCE-HY-W050000R-25MG,MCE-HY-W050000R-5MG
Hersteller: MedchemExpress
Kategorie: Biochemikalien
OR-1855 (Standard) is an analytical standard of OR-1855 (HY-W050000). This product is intended for research and analytical applications. OR-1855, an active metabolite of Levosimendan (HY-14286), has effect on myometrial contractility. OR-1855 exerts anti-inflammatory effects by inhibiting IL-1beta-induced ROS formation and NAD(P)H oxidase-dependent superoxide radical generation in HUVECs. OR-1855 inhibits IL-1beta-induced phosphorylation p38 MAPK, ERK1/2, c-Jun and JNK in HUVECs. OR-1855 can be used for the study of inflammation[1][2][3].
Molekulargewicht: 203.25
CAS Nummer: [101328-85-2]
Formel: C11H13N3O
Target-Kategorie: Drug Metabolite,ERK,p38 MAPK,Reactive Oxygen Species (ROS),Reference Standards
Anwendungsbeschreibung: MCE Product type: Reference Standards